Second STOP After Pioglitazone Priming in CML Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

Chronic Myeloid Leukemia (CML)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Centre Hospitalier de Versailles, Le Chesnay, France
Contact: Study coordinator (Philippe rousselot) · phrousselot@ght78sud.fr
Hôpital Bicêtre, Le Kremlin-Bicêtre, France
CHU Lyon, Lyon, France
Contact: Study coordinator (Marie Balsat)
CHU de Nantes, Nantes, France
CHU de Rennes, Rennes, France
IUCT, Toulouse, France
Contact: Study coordinator (Fran HUGUET)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

Chronic Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Juvenile Myelomonocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Gainesville, United States

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

Chronic Myeloid Leukemia (CML)

Abroad (travel likely)RecruitingPHASE2

Bordeaux, France · Lille, France

Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

Acute Myeloid Leukemia (AML) · Chronic Myeloid Leukemia · Myelodysplastic Syndromes (MDS)

Abroad (travel likely)RecruitingPHASE2

Saint Petersburg, Russia